Grapiprant is a veterinary non-steroidal anti-inflammatory drug from the piprant class, developed as a prostaglandin receptor antagonist. It was approved in March 2016 by the FDA's Center for Veterinary Medicine as a non-cyclooxygenase inhibiting NSAID for veterinary use.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Grapiprant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ciclopirox olamine
pharmaceutical raw material
Ginsenoside Rb1
pharmaceutical raw material
Trepibutone
pharmaceutical raw material
Bezafibrate
pharmaceutical raw material
The international HS code for Grapiprant (CAS 415903-37-6) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea
HZVLFTCYCLXTGV-UHFFFAOYSA-N
CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C
Sourcing Grapiprant?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.